{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:02:19Z","timestamp":1791993739620,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL081671"],"award-info":[{"award-number":["R01HL081671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.contraception.2010.03.009","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T08:30:03Z","timestamp":1272443403000},"page":"366-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation"],"prefix":"10.1016","volume":"82","author":[{"given":"Jessica R.","family":"Meendering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta N.","family":"Torgrimson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole P.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Minson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.03.009_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2008.07.025","article-title":"Ethinyl estradiol to desogestrel ratio impacts endothelial function in young women","volume":"79","author":"Meendering","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.009_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.fertnstert.2008.06.054","article-title":"Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring","volume":"92","author":"Torgrimson","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.009_bib3","first-page":"H103","article-title":"Endothelial function across an oral contraceptive cycle in women using leveonorgestrel and ethinyl estradiol","volume":"288","author":"Torgrimson","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.contraception.2008.07.024","article-title":"Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women","volume":"79","author":"Lizarelli","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.009_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2010.03.009_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002512-200421130-00004","article-title":"New progestogens: a review of their effects in perimenopausal and postmenopausal women","volume":"21","author":"Sitruk-Ware","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.contraception.2010.03.009_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200201000-00003","article-title":"Progestogens in hormonal replacement therapy: new molecules, risks, and benefits","volume":"9","author":"Sitruk-Ware","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2010.03.009_bib8","doi-asserted-by":"crossref","first-page":"11F","DOI":"10.1016\/S0002-9149(01)02218-4","article-title":"Vasomotor and vascular effects of hormone replacement therapy","volume":"90","author":"Ganz","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mob.2002.119179","article-title":"Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII","volume":"186","author":"van Rooijen","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.009_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0163-7258(83)90023-2","article-title":"Progestins can mimic, inhibit and potentiate the actions of androgens","volume":"23","author":"Bardin","year":"1983","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.contraception.2010.03.009_bib11","doi-asserted-by":"crossref","first-page":"H1630","DOI":"10.1152\/ajpheart.01314.2007","article-title":"Estrogen, medroxyprogesterone acetate, endothelial function and biomarkers of cardiovascular risk in young women","volume":"294","author":"Meendering","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.CIR.0000030940.73167.4E","article-title":"Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance","volume":"106","author":"Sorensen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2010.03.009_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Karattenmacher","year":"2000","journal-title":"Contraception"},{"issue":"Suppl 3","key":"10.1016\/j.contraception.2010.03.009_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697130500330382","article-title":"Pharmacology of different progestogens: the special case of drospirenone","volume":"8","author":"Sitruk-Ware","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2010.03.009_bib15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.CIR.91.5.1314","article-title":"Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo","volume":"91","author":"Joannides","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2010.03.009_bib16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.03.009_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.03.009_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/jappl.2001.91.2.929","article-title":"Improved analysis of brachial artery ultrasound using a novel edge-detection software system","volume":"91","author":"Woodman","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1152\/japplphysiol.01245.2003","article-title":"Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans","volume":"97","author":"Pyke","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1113\/jphysiol.2005.089755","article-title":"The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function","volume":"568","author":"Pyke","year":"2005","journal-title":"J Physiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib21","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1152\/japplphysiol.01024.2006","article-title":"Peak vs. total reactive hyperemia: which determines the magnitude of flow-mediated dilation?","volume":"102","author":"Pyke","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/cs0990261","article-title":"Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery after different circulatory occlusion conditions","volume":"99","author":"Berry","year":"2000","journal-title":"Clin Sci"},{"key":"10.1016\/j.contraception.2010.03.009_bib23","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1152\/japplphysiol.01047.2004","article-title":"Measuring peripheral resistance and conduit arterial structure in humans using doppler ultrasound","volume":"98","author":"Naylor","year":"2005","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2007.11.044","article-title":"Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women","volume":"51","author":"Rossi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0735-1097(95)00327-4","article-title":"Close relation of endothelial function in the human coronary and peripheral circulations","volume":"26","author":"Anderson","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib26","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.009_bib27","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ajog.2004.01.061","article-title":"Safety concerns and health benefits associated with oral contraception","volume":"190","author":"Burkman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.009_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00003081-200103000-00010","article-title":"Oral contraceptives: current status","volume":"44","author":"Burkman","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.009_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0010-7824(97)00029-2","article-title":"Estrogen and progestin components of oral contraceptives: relationship to vascular disease","volume":"55","author":"Carr","year":"1997","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1016\/j.contraception.2010.03.009_bib30","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1016\/S0010-7824(00)00146-3","article-title":"Emerging evidence on oral contraceptives and arterial disease","volume":"62","author":"Heinemann","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.009_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0010-7824(03)00073-8","article-title":"Oral contraceptives use and the risk of myocardial infarction: a meta-analysis","volume":"68","author":"Khader","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.009_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2010.03.009_bib33","first-page":"182","article-title":"Clinical profile of contraceptive progestins","volume":"9","author":"Benagiano","year":"2004","journal-title":"Eur J Clin Chem Clin Biochem"},{"issue":"Suppl","key":"10.1016\/j.contraception.2010.03.009_bib34","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1067\/mob.2001.117415","article-title":"Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy","volume":"185","author":"Hammond","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.009_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.03.009_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"issue":"Suppl 3","key":"10.1016\/j.contraception.2010.03.009_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14730782.2000.12288986","article-title":"Drospirenone\u2014a new progestogen with antimineralocorticoid activity, resembling natural progesterone","volume":"5","author":"Oelkers","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.03.009_bib38","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/hc1202.105945","article-title":"Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen","volume":"105","author":"Wakatsuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2010.03.009_bib39","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.ATV.17.10.2004","article-title":"Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men","volume":"17","author":"Herman","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.contraception.2010.03.009_bib40","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2010.03.009_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone, a progestogen with antimineralocorticoid properties: a short review","volume":"217","author":"Oelkers","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2010.03.009_bib42","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.009_bib43","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2010.03.009_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0010-7824(85)90005-8","article-title":"Oral contraceptives, lipids and cardiovascular disease","volume":"31","author":"Fotherby","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.009_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0010-7824(02)00537-1","article-title":"A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism","volume":"67","author":"Gaspard","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.009_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.009_bib47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9343(99)00261-2","article-title":"Cholesterol lowering and endothelial function","volume":"107","author":"Vogel","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2010.03.009_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0033-0620(98)80008-X","article-title":"Cholesterol, cholesterol lowering, and endothelial function","volume":"41","author":"Vogel","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.contraception.2010.03.009_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00041433-199806000-00009","article-title":"Cholesterol, endothelial function and cardiovascular disease","volume":"9","author":"Wilkinson","year":"1998","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.contraception.2010.03.009_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cardiores.2004.12.012","article-title":"Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen","volume":"66","author":"Dubey","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.contraception.2010.03.009_bib51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/japplphysiol.00248.2005","article-title":"Women, hormones, and clinical trials: a beginning, not an end","volume":"99","author":"Miller","year":"2005","journal-title":"J Appl Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2010.03.009_bib52","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.maturitas.2003.09.015","article-title":"Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection","volume":"46","author":"Rosano","year":"2003","journal-title":"Maturitas"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:09:30Z","timestamp":1762117770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0010782410000995"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.03.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2010.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}